Brief Update on Outstanding Items from the 2012 Bilateral Meeting

A) Nonprescription Drug Label Approval Process Issue:

Following confirmation, at the 2011 bilateral meeting, that TPD has always reviewed draft labels for Category IV monograph or Labeling Standard submissions, ASC questioned whether the final marketed labels are also reviewed and if they could be accessible to the general public via the external Drug Product Database (DPD).